NDC 43063-857 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC43063-857

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (7)

Package NDCDescriptionSince
43063-857-022 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-857-02)Jun 4, 2018
43063-857-044 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-857-04)Jun 12, 2018
43063-857-055 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-857-05)Jun 12, 2018
43063-857-066 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-857-06)Jun 4, 2018
43063-857-088 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-857-08)Jun 7, 2018
43063-857-1010 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-857-10)Jun 18, 2018
43063-857-2020 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-857-20)Aug 21, 2018

Other Ondansetron products